Jasper Therapeutics (JSPR) Other Working Capital Changes (2022 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Other Working Capital Changes of -$468000.0 for Q4 2025, down 82.81% year-over-year from -$2.7 million in Q4 2024, and down 3.54% quarter-over-quarter from -$452000.0 in Q3 2025.
Jasper Therapeutics (JSPR) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Jasper Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$468000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 82.81% year-over-year to -$468000.0; the TTM figure through Dec 2025 stood at -$1.7 million (down 71.63% YoY), while the FY2025 annual figure was -$1.7 million, down 71.63% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$468000.0, down from -$452000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.3 million in Q4 2025, with the low at -$1.4 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is $205000.0 (2025), against an average of $260500.0.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes surged 85.71% in 2023, then sank 1356.25% in 2024.
- Jasper Therapeutics' Other Working Capital Changes stood at $2.1 million in 2022, then slumped by 110.83% to -$228000.0 in 2023, then declined by 12.28% to -$256000.0 in 2024, then tumbled by 82.81% to -$468000.0 in 2025.
- Business Quant data shows JSPR's Other Working Capital Changes at -$468000.0 in Q4 2025, -$452000.0 in Q3 2025, and -$435000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jasper Therapeutics | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -468,000.00 |
| Dec 31, 2025 | -468,000.00 |
| Dec 31, 2025 | -468,000.00 |
| Sep 30, 2025 | -452,000.00 |
| Sep 30, 2025 | -452,000.00 |
| Sep 30, 2025 | -452,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Mar 31, 2025 | -315,000.00 |
| Mar 31, 2025 | -315,000.00 |
| Mar 31, 2025 | -315,000.00 |
| Dec 31, 2024 | -256,000.00 |
| Dec 31, 2024 | -256,000.00 |
| Dec 31, 2024 | -256,000.00 |
| Sep 30, 2024 | -247,000.00 |
| Sep 30, 2024 | -247,000.00 |
| Sep 30, 2024 | -247,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Jun 30, 2024 | -237,000.00 |